In the corresponding tumor organoids, in addition to the same SNV in the POLE gene, several other point mutations were identified: KRAS (p.G12D), TP53 (p.V173A), and NOTCH2 (p.R2051Q). This evidence concerns the gene NOTCH2 and neoplasm.